03 November 1997
Antibiotic sensitivity of Enterococcus species strains cultured from hospital and medical centre patientsEugenia Gospodarek, Iwona Kania, Małgorzata Białek
Med Sci Monit 1997; 3(6): BR801-806 :: ID: 501768
The isolation of Enterococcus species bacteria from clinical materials has recently become quite a frequent procedure. These micro-organisms are frequently resistant to many antibiotics, thus they often create therapeutic problems. The purpose of our study was to analyse Enterococcus spp. occurrence in diagnostic materials taken from the patients of the State Clinical Hospital of the Medical University in Bydgoszcz and from patients treated in medical centres (ambulatory centres), and to evaluate the sensitivity of these bacteria to antibacterial drugs. The analysis encompassed 1002 enterococcal strains coming from clinical material and 209 strains from medical centre material. The identification of Enterococcus spp. was based on Slidex-Strepto-kit (Bio-Merieux) and API 20 Strep (Bio-Merieux) test results. Antibiotic sensitivity was evaluated by disk-diffusion method. Resistance to high aminoglycoside concentrations (500 mg/l - gentamycin and 2000 mg/l streptomycin) was evaluated on BHI (Brain-Heart-Infusion, Bio-Merieux) agar. Among 8 800 micro-organism strains isolated in 1995, 1 211 (13.8%) strains were classified as enterococci strains. 1 002 (82.7%) strains originated from hospital patients, 209 (17.3%) strains were isolated from out-patient patients. The total of 768 (63.4%) enterococci was isolated in monocultures out of which number 629 (81.9%) belonged to species E. faecalis, while 139 (18.1%) - to E. faecium. None of enterococci strains under study was resistant to glycopeptides. None of strains produced (-lactamase in nitrocefin test (cefinaze, BBL). Enterococci strains isolated from urine in high percentage were sensitive to nitrofurantoin; this pertained to both hospital patients (80.6%) and medical centre patients (93.4%). About 30% of enterococci isolated from hospital patients and about 7% strains from medical centre patients were resistant to high concentration of aminoglycosides.
key words: Enterococcus spp, resistance to antibiotics, resistance to high level concentrations of aminoglycosides
Keywords: Enterococcus spp, resistance to antibiotics, resistance to high level concentrations of aminoglycosides
27 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC)
Med Sci Monit 2021; 27:e934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
09 July 2021 : Database AnalysisA Simple Clinical Prediction Tool for COVID-19 in Primary Care with Epidemiology: Temperature-Leukocytes-CT...
Med Sci Monit In Press; DOI: 10.12659/MSM.931467
24 Sep 2021 : Clinical ResearchA Single-Center Study of a Resin Inlay Dental Implant-Fixed Prosthesis for Closing Proximal Contact Loss in...
Med Sci Monit In Press; DOI: 10.12659/MSM.933809
24 Sep 2021 : Database AnalysisRelationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Med Sci Monit In Press; DOI: 10.12659/MSM.933448
24 Sep 2021 : Database AnalysisA Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors
Med Sci Monit In Press; DOI: 10.12659/MSM.933559
Most Viewed Current Articles
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700